Shingles vaccine response in patients on immune-modifying drugs
Part of Immune system & allergy, Infections clinical trials.
This study tests a new shingles vaccine in people with psoriasis or myelofibrosis, some of whom take immune-modifying medications. Researchers want to understand how well the vaccine works and how the immune system responds in these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have either psoriasis or myelofibrosis (a blood marrow condition)
- You are expected to live at least 12 more months
- You are willing to sign an informed consent form
- You have not previously enrolled in this specific study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well the shingles vaccine works in people with weakened immune systems due to conditions like rheumatoid arthritis, cancer, or multiple sclerosis. It aims to see if the vaccine is safe and effective for these patients.
This study tests whether the Shingrix vaccine prevents shingles in people with CLL (a type of blood cancer). It will look at how well the vaccine works and helps your immune system fight the virus.
This study looks at how well the shingles vaccine works in people with autoimmune inflammatory diseases. Researchers want to make sure the vaccine provides good protection for patients whose immune systems are affected by their condition or treatment.
This trial tests whether Shingrix (a shingles vaccine) is safe and works well in adults with rheumatic or immune-related conditions. It compares Shingrix to a placebo (inactive shot) to see how well it prevents shingles and affects immune symptoms.
This study offers the Shingrix shingles vaccine for free to adults with inflammatory rheumatic diseases. It compares how well the vaccine works in people taking immune-suppressing drugs versus those not taking them.
This study tests how well the shingles vaccine (Shingrix) works in people with lupus who take immune-suppressing medications. Researchers want to understand if the vaccine provides good protection in lupus patients, since their immune systems work differently.
Hear when a new RZV Vaccine (Shingrix ®) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.